Lilly Ventures Spins Out from Eli Lilly

Lilly Ventures has spun out from drugmaker Eli Lilly & Co., in order to offer its employees more competitive compensation packages, according to VentureWire. As part of the deal, Lilly Ventures secured a new $200 million capital commitment from its former parent company.

Connect with your peers at the 9th Annual PartnerConnect West in San Francisco on September 27–28.

Sign up to our Newsletter

Receive updates from our PE HUB Wire and Top Stories of the Week newsletters:

We will not send you spam, and we don't share your email address with 3rd parties.